Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice

Journal of Neuroimmunology

Volumn 84, Issue 2, 1998, Pages 188-197

  Pedchenko, Tatyana V ^a   Levine, Steven M ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Deferoxamine; Desferal; Desferrioxamine; DFO; Free radicals; Iron histochemistry; Male SJL mice

Indexed keywords

DEFEROXAMINE; HETASTARCH;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; IRON CHELATION; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCAVENGING SYSTEM;

ANIMALS; DEFEROXAMINE; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FERRIC COMPOUNDS; FREE RADICALS; HETASTARCH; IMMUNOHISTOCHEMISTRY; IRON; IRON CHELATING AGENTS; MALE; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; MYELIN SHEATH; TISSUE DISTRIBUTION;

EID: 0032522199     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00256-7     Document Type: Article

References (43)

1. Bebo B.F. Jr., Vandenbark A.A., Offner H. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J. Neurosci. Res. 45:1996;680-689.
2. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87:1990;1620-1624.
3. Borg, D.C., 1993. Oxygen free radicals and tissue injury. A reference outline. In: Tarr, M., Samson, F. (Eds.), Oxygen Free Radicals in Tissue Damage. Birkhauser, Boston, pp. 12-53.
4. Borg, D.C., Schaich, K.M., 1988. Iron and iron-derived radicals. In: Halliwell, B. (Ed.), Oxygen Radicals and Tissue Injury. Federation of American Societies for Experimental Biology, Bethesda, MD, pp. 20-26.
5. Bowern N., Ramshaw I.A., Clark I.A., Doherty P.C. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J. Exp. Med. 160:1984;1532-1543.
6. Brett R., Rumsby M.G. Evidence of free radical damage in the central nervous system of guinea pigs at the prolonged acute and early relapse stages of chronic relapsing experimental allergic encephalomyelitis. Neurochem. Int. 23:1993;35-44.
7. Claudio L., Kress Y., Factor J., Brosnan C.F. Mechanisms of edema formation in experimental autoimmune encephalomyelitis: the contribution of inflammatory cells. Am. J. Pathol. 137:1990;1033-1045.
8. Connor J.R., Menzies S.L. Altered cellular distribution of iron in the central nervous system of myelin deficient rats. Neuroscience. 34:1990;265-271.
9. Connor J.R., Menzies S.L., St. Martin S.M., Mufson E.J. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. Res. 27:1990;595-611.
10. Craelius W., Migdal M.W., Luessenhop C.P., Sugar A., Mihalakis I. Iron deposits surrounding multiple sclerosis plaques. Arch. Pathol. Lab. Med. 106:1982;397-399.
11. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
12. Cross A.H., Keeling R.M., Goorha S., San M., Rodi C., Wyatt P.S., Manning P.T., Misko T.P. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 71:1996;145-153.
13. Cua D.J., Hinton D.R., Kirkman L., Stohlman S.A. Macrophages regulate induction of delayed-type hypersensitivity and experimental allergic encephalomyelitis in SJL mice. Eur. J. Immunol. 25:1995;2318-2324.
14. Dang S., Rasmussen C.A., LeVine S.M. Immunocytochemical localization of desferrioxamine in the liver, kidney and brain of developing and adult mice: implications for drug processing and therapeutic mechanisms. Res. Commun. Mol. Pathol. Pharmacol. 86:1994;43-57.
15. Erb G., Osterbur D.L., LeVine S.M. The distribution of iron in the brain: a phytogenetic analysis using iron histochemistry. Dev. Brain Res. 93:1996;120-128.
16. Francois C., Nguyen-Legros J., Percheron G. Topographical and cytological localization of iron in rat and monkey brains. Brain Res. 215:1981;317-322.
17. Goldmuntz E.A., Brosnan C.F., Norton W.T. Prazosin treatment suppresses increased vascular permeability in both acute and passively transferred experimental autoimmune encephalomyelitis in the Lewis rat. J. Immunol. 137:1986;3444-3450.
18. Gutteridge J.M.C. Iron and oxygen radicals in brain. Ann. Neurol. 32:1992;S16-S21.
19. Guy J., Ellis E.A., Rao N.A. Hydrogen peroxide localization in experimental optic neuritis. Arch. Ophthalmol. 108:1990;1614-1621.
20. Guy J., McGoray S., Xioping Q., Fitzsimmons J., Mancuso A., Rao N. Conjugated desferrioxamine reduces blood-brain barrier disruption in experimental optic neuritis. Ophthalmic Res. 26:1994;310-323.
21. Hallaway P.E., Eaton J.W., Panter S.S., Hedlund B.E. Modulation of desferrioxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc. Natl. Acad. Sci. U.S.A. 86:1989;10108-10112.
22. Halliwell B., Gutteridge J.M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219:1984;1-14.
23. Hewett S.J., Misko T.P., Keeling R.M., Behrens M.M., Choi D.W., Cross A.H. Murine encephalitogenic lymphoid cells induce nitric oxide synthase in primary astrocytes. J. Neuroimmunol. 64:1996;201-208.
24. Hill J.M., Switzer R.C. The regional distribution and cellular localization of iron in the rat brain. Neuroscience. 11:1984;595-603.
25. LeVine S.M. Oligodendrocytes and myelin sheaths in normal, quaking and shiverer brains are enriched in iron. J. Neurosci. Res. 29:1991;413-419.
26. LeVine S.M. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 760:1997;298-303.
27. LeVine S.M., Macklin W.B. Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. J. Neurosci. Res. 26:1990;508-512.
28. Lin R.F., Lin T.-S., Tilton R.G., Cross A.H. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:1993;643-648.
29. MacMicking J.D., Willenborg D.O., Weidemann M.J., Rockett K.A., Cowden W.B. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176:1992;303-307.
30. Maruyama M., Pieper G.M., Kalyanaraman B., Hallaway P.E., Hedlund B.E., Gross G.J. Effects on hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs. J. Cardiovasc. Pharmacol. 17:1991;166-175.
31. Milford C.M., Lynch S.G., Cross R.S., LeVine S.M. Testing lazaroids U-74389G and U-83836E for therapeutic value in experimental allergic encephalomyelitis in the Lewis rat. Res. Commun. Mol. Pathol. Pharmacol. 87:1995;353-358.
32. Moore G.R.W., Traugott U., Farooq M., Norton W.T., Raine C.S. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids. Lab. Invest. 51:1984;416-424.
33. Rajan K.S., Colburn R.W., Davis J.M. Distribution of metal ions in the subcellular fractions of several rat brain areas. Life Sci. 18:1976;423-432.
34. Reif D.W. Ferritin as a source of iron for oxidative damage. Free Radic. Biol. Med. 12:1992;417-427.
35. Reif D.W., Simmons R.D. Nitric oxide mediates iron release from ferritin. Arch. Biochem. Biophys. 283:1990;537-541.
36. Ruuls S.R., Bauer J., Sontrop K., Huitinga I., 't-Hart B.A., Dijkstra C.D. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 56:1995;207-217.
37. Stadtman E.R. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic. Biol. Med. 9:1990;315-325.
38. Stadtman E.R., Oliver C.N. Metal-catalyzed oxidation of proteins. Physiological consequences. J. Biol. Chem. 266:1991;2005-2008.
39. Stohl W., Gonatas N.K. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat. J. Immunol. 121:1978;844-850.
40. 125I -human gamma-globulin J. Immunol. 122:1979;920-925.
41. Tangoren M., Levi L., Wolf A., Broadwell R., Hedlund B. Reducing brain edema in experimental concussive brain injury with post-injury treatment by polysaccharide-desferrioxamine. Soc. Neurosci. Abstr. 17:1991;163.
42. Willenborg D.O., Bowern N.A., Danta G., Doherty P.C. Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen. J. Neuroimmunol. 17:1988;127-135.
43. Zhao W., Tilton R.G., Corbett J.A., McDaniel M.L., Misko T.P., Williamson J.R., Cross A.H., Hickey W.F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:1996;123-133.